Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02267928 · ClinicalTrials.gov registry record · NA
Information Presentation Formats
A NA study of Meningioma, sponsored by Carnegie Mellon University.
- Completed
- Registry status
- NA
- Development phase
- 305
- Enrollment target
- 1
- Study location
NCT02267928 is a NA study of Meningioma that has completed, run by Carnegie Mellon University. The registered enrollment target is 305 participants, above the 85-participant average among 21 other Meningioma trials with a reported enrollment target (259% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02267928, a NA study of Meningioma, has completed, sponsored by Carnegie Mellon University.
- COMPLETED
- Registry status
- NA
- Development phase
- 305 participants
- Enrollment target
- 1
- Study location
Study Summary
Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. The investigators seek to understand whether the elicitation of symptom admission by patients can predict people's perceived risk of the medical condition and voluntary pursuit of medical information.
Conditions Studied
Interventions
- OTHER Check Symptoms
- OTHER Uncheck Symptoms
- OTHER Experienced
- OTHER Not Experienced
Study Locations (1)
Pennsylvania
- Carnegie Mellon University - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 305 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02267928
The ClinicalTrials.gov registry entry for NCT02267928 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 85-participant average among 21 other Meningioma trials with a reported enrollment target (259% higher). The listed sponsor is Carnegie Mellon University, which has 37 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Meningioma appearing as the primary indexed condition, and to 4 interventions - of which Check Symptoms is the first listed.
NCT02267928 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02267928 about?
NCT02267928 is a clinical study titled "Information Presentation Formats". Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. The investigators seek to understand whether the ...
What is the current status of trial NCT02267928?
This trial is currently completed. It is a NA study. The enrollment target is 305 participants. The study started on 2014-10. Estimated completion is 2016-05.
What conditions does trial NCT02267928 study?
This clinical trial studies the following conditions: Meningioma.
What interventions are being tested in trial NCT02267928?
The interventions under investigation include: Check Symptoms (OTHER), Uncheck Symptoms (OTHER), Experienced (OTHER), Not Experienced (OTHER).
Who is sponsoring clinical trial NCT02267928?
This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02267928 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Meningioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer)
RECRUITING · NA
-
Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma
RECRUITING · NA
-
A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
ACTIVE NOT RECRUITING · NA
-
Stereotactic Body Radiotherapy for Spine Tumors
COMPLETED · NA
-
Abemaciclib in Newly Diagnosed Meningioma Patients
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.